OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th
Rhea-AI Summary
OraSure (NASDAQ: OSUR) will report first quarter 2026 financial results and host a conference call at 5:00 p.m. ET on May 6, 2026. A live webcast will be available on the company investor relations website and will be archived shortly after the call.
Participants should register and join at least 10 minutes before the scheduled start.
Positive
- None.
Negative
- None.
News Market Reaction – OSUR
In the Apr 23 session, OSUR declined 2.24%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 09 | Earnings date notice | Neutral | -0.3% | Set timing for Q4 2025 results and earnings conference call. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior earnings-date scheduling news for OSUR saw a modestly negative but limited price reaction.
Over the past several months, OraSure has reported Q4 2025 results with $26.8M revenue and $199.3M cash, highlighted new product submissions, and faced activist pressure from Altai Capital. Governance changes, including a cooperation agreement and board refresh, were accompanied by multiple SEC filings and insider share purchases in March 2026. Against this backdrop, today’s Q1 2026 earnings date announcement continues the regular cadence of communications following the February 25, 2026 Q4 2025 earnings and its earlier earnings-date notice on Feb 9, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BETHLEHEM, Pa., April 22, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2026 financial results and certain business developments for 5 p.m. ET on May 6, 2026.
A webcast of the conference call will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. Please click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The webcast will be archived on OraSure’s website shortly after the call has ended.
About OraSure Technologies, Inc.
OraSure Technologies, Inc. (“OraSure” and “OTI”) transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. OTI improves access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. Together with its wholly-owned subsidiaries, DNA Genotek Inc., Sherlock Biosciences, Inc., and BioMedomics, Inc., OTI is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. OTI’s portfolio of products is sold globally to clinical laboratories, hospitals, physicians’ offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct to consumers. For more information, please visit www.orasure.com
| Investor Contact: | Media Contact: | |
| Jason Plagman | Amy Koch | |
| VP, Investor Relations | Director, Corporate Communications | |
| investorinfo@orasure.com | media@orasure.com |
